log in search issues home
about us
subscriptions
from the editor
sample issue
customer service
CME
special offers

click here

Concise. Unbiased. Informative.

CME CreditCME CREDIT
Save your issues to review. The 2009 CME questions will be available December 1st.



PromotionPROMOTIONAL MAILING
Activate your new subscription now! Don't forget to enter your promo code.



BTP Gift SubscriptionBTP makes a great gift for the holidays or a new medical professional.
Plus, get 3 bonus issues added to your subscription as our thanks.



BTP Bound VolumeBTP Bound Volume
2003-2007

Currently available for $29.95. Order today!



Questions?QUESTIONS?
Contact us for answers regarding the newsletter or subscription information.
  IN THIS MONTH'S ISSUE:
July 2009

Comparing Antidepressants
Among new-generation antidepressants, sertraline (Zoloft and others) may be the best first-line medication.
Antipsychotics in Dementia Patients: More Data on Risk
Several studies found a higher risk of adverse events and death in dementia patients prescribed antipsychotics.
DBS: Research Continues
Deep brain stimulation may benefit patients with treatment-resistant depression but carries a risk of serious adverse events.
In Brief
Prenatal Vitamin D Deficiency May Play a Role in Schizophrenia; Depression May Decrease Bone Mineral Density
Ginkgo Biloba: Another Negative Trial in Dementia
In a double-blind trial, Ginkgo biloba did not provide benefit and elevated the risk of stroke in dementia patients.

In addition to his position as Editor of BTP, Dr. Alan Gelenberg also serves as President and CEO of Healthcare Technology Systems. We invite you to visit the HTS website to learn more.